Skip to main content
Premium Trial:

Request an Annual Quote

BGI Extends Expiration Date for Complete Genomics Tender Offer, Gets China OK

NEW YORK (GenomeWeb News) – Complete Genomics said in a filing with the US Securities and Exchange Commission today that BGI-Shenzhen's tender offer to acquire the firm has been extended to midnight, New York City time, on Jan. 18.

The $118 million bid, which was launched in September, was scheduled to expire at midnight last Friday. Complete Genomics said that as of the close of business on Jan. 11, approximately 29.3 million shares representing around 83 percent of its outstanding common stock had been validly tendered and not withdrawn.

Complete Genomics also said in the SEC filing that the National Development and Reform Commission of the People's Republic of China had granted clearance of the proposed acquisition last Friday. The deal passed US Federal Trade Commission review last week.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.